Evidence map›Paper›PMID 1567381›Full record

ArticleThe Biochemical journal1992

Effect of intestinal chylomicron secretory blockade on apolipoprotein synthesis in the newborn piglet.

D D Black

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

D D BlackDepartment of Pediatrics, Wyler Children's Hospital, University of Chicago, IL 60637.
Comer Children's Hospital · US

Funding

INTESTINAL LIPOPROTEINS IN THE NEONATER29HD022551 · NICHD · UNIVERSITY OF CHICAGO · PI BLACK, DENNIS DARREL · 1987 to 1991
–
NICHD NIH HHS R29 HD22551
6 · The paper itself

Abstract

Pluronic L-81 is a hydrophobic surfactant which blocks intestinal chylomicron secretion at the pre-Golgi level without affecting triacylglycerol uptake and re-esterification. To study the effects of such blockade on apolipoprotein synthesis, newborn female piglets received 24 h intraduodenal infusions of low-triacylglycerol, or high-triacylglycerol with or without Pluronic L-81, diets, followed by determination of apolipoprotein (apo) B-48, A-I and A-IV synthesis and content and apo B and A-IV mRNA levels in the small intestine. Jejunal apo B-48 content, synthesis and mRNA levels were down-regulated below basal levels by the addition of Pluronic to the high-triacylglycerol infusion. The normal increase in apo A-I synthesis induced by triacylglycerol absorption was ablated in both jejunum and ileum, even though the expected increase in apo A-I content in jejunum still occurred. Although attenuated, the expected increase in jejunal apo A-IV synthesis and mRNA levels with triacylglycerol absorption was still present with Pluronic treatment. These results suggest very different mechanisms of cellular regulation and trafficking for the various apolipoproteins incorporated into nascent intestinal chylomicrons. Apo B may be specifically down-regulated by the chylomicron secretory blockade induced by Pluronic L-81.

Indexed as

AnimalsAnimals, NewbornApolipoprotein A-IApolipoprotein B-48ApolipoproteinsApolipoproteins AApolipoproteins BChylomicronsFemaleIntestinal MucosaIntestine, SmallJejunumPoloxaleneRNA, MessengerSwineTriglyceridesApolipoprotein A-Iapolipoprotein A-IVApolipoprotein B-48ApolipoproteinsApolipoproteins AApolipoproteins BChylomicronsPoloxaleneRNA, MessengerTriglyceridesTritium

Identifiers

PMID1567381
PMCPMC1130996
OpenAlexW136018797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.